Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

35 results

Sort by

List item

Human medicine European public assessment report (EPAR): Valtropin

somatropin, Turner Syndrome; Dwarfism, Pituitary
Date of authorisation: 24/04/2006, , Revision: 5, Withdrawn, Last updated: 14/08/2012
List item

Human medicine European public assessment report (EPAR): Folotyn

Pralatrexate, Lymphoma, T-Cell
Date of refusal: 21/06/2012, , Refused, Last updated: 11/07/2012
List item

Human medicine European public assessment report (EPAR): Filgrastim ratiopharm

filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 15/09/2008, , Revision: 1, Withdrawn, Last updated: 20/07/2011
List item

Human medicine European public assessment report (EPAR): Sovrima

idebenone, Friedreich Ataxia
Date of refusal: 27/04/2009, , Refused, Last updated: 31/12/2009
List item

Human medicine European public assessment report (EPAR): Mylotarg

gemtuzumab ozogamicin, Leukemia, Myeloid, Acute
Date of refusal: 14/04/2008, , Refused, Last updated: 24/01/2008
List item

Human medicine European public assessment report (EPAR): Alpheon

recombinant human interferon alfa-2a, Hepatitis C, Chronic
Date of refusal: 05/09/2006, , Refused, Last updated: 28/06/2006
List item

Human medicine European public assessment report (EPAR): Exondys

eteplirsen, Muscular Dystrophy, Duchenne
Date of refusal: 06/12/2018, , Refused, Last updated: 12/12/2018
List item

Human medicine European public assessment report (EPAR): Qutavina

teriparatide, Osteoporosis
Date of authorisation: 27/08/2020, , Withdrawn, Last updated: 18/01/2021
List item

Human medicine European public assessment report (EPAR): Turalio

Pexidartinib, Giant Cell Tumor of Tendon Sheath; Synovitis, Pigmented Villonodular
Date of refusal: 28/10/2020, , , Refused, Last updated: 18/12/2020
List item

Human medicine European public assessment report (EPAR): Lextemy

bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms ,
Withdrawn, Last updated: 24/02/2021